Table 2

Relationship between factors and lymphedema in ovarian and uterine cancer patients who underwent pelvic lymph node dissection (univariate analysis; N = 680)

Factor

Category

N

No. cases of lymphedema

Lymphedema incidence (%)

p value*


Cancer type

Ovarian

133

28

21.1

Cervical

252

75

29.8

Endometrial

295

82

27.8

0.175


Age

< 53 years

342

93

27.2

≥ 53 years

338

92

27.2

1.000


Retroperitoneal approach**

Closing

457

131

28.7

Opening

79

24

30.4

0.789


Omentectomy

-

569

160

28.1

+

111

25

22.5

0.245


Enterectomy

-

670

181

27.0

+

10

4

40.0

0.473


Salpingo-oophorectomy

-

160

45

28.3

Unilateral

87

25

28.7

Bilateral

433

115

26.6

0.873


Hysterectomy

-

12

4

33.3

Total

206

53

25.7

Modified radical

196

51

26.0

Radical

266

77

29.0

0.767


Neo-adjuvant chemotherapy

-

645

173

26.8

+

35

12

34.3

0.334


Adjuvant chemotherapy

-

393

111

28.2

+

287

74

25.8

0.487


Post-operative radiation

-

548

136

24.8

+

132

49

37.1

0.006


Para-aortic lymph node dissection

-

516

133

25.8

+

164

52

31.7

0.158


Total

680

185

27.2


* Fisher's exact test

** Except for 144 patients for whom this information was unknown.

Tada et al. BMC Cancer 2009 9:47   doi:10.1186/1471-2407-9-47

Open Data